BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. ✅
Go to Publication ✅
Gut (Gut ) Vol: 66 Issue 5 Pages: 863-871 Pub: 2017 May Epub: 2016 Feb 4 Authors Lee T , Clavel T , Smirnov K , Schmidt A , Lagkouvardos I , Walker A , Lucio M , Michalke B , Schmitt-Kopplin P , Fedorak R , Haller D , |
|
|
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. ✅
Go to Publication ✅
Gut (Gut ) Vol: 66 Issue 5 Pages: 863-871 Pub: 2017 May Epub: 2016 Feb 4 Authors Lee T , Clavel T , Smirnov K , Schmidt A , Lagkouvardos I , Walker A , Lucio M , Michalke B , Schmitt-Kopplin P , Fedorak R , Haller D , |
|
|
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. ✅
Go to Publication ✅
Gut (Gut ) Vol: 66 Issue 5 Pages: 863-871 Pub: 2017 May Epub: 2016 Feb 4 Authors Lee T , Clavel T , Smirnov K , Schmidt A , Lagkouvardos I , Walker A , Lucio M , Michalke B , Schmitt-Kopplin P , Fedorak R , Haller D , |
|
|
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. ✅
Go to Publication ✅
Gut (Gut ) Vol: 66 Issue 5 Pages: 863-871 Pub: 2017 May Epub: 2016 Feb 4 Authors Lee T , Clavel T , Smirnov K , Schmidt A , Lagkouvardos I , Walker A , Lucio M , Michalke B , Schmitt-Kopplin P , Fedorak R , Haller D , |
|
|
Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. ✅
Go to Publication ✅
FEMS microbiology ecology (FEMS Microbiol Ecol ) Vol: 83 Issue 1 Pages: 161-75 Pub: 2013 Jan Epub: 2012 Aug 28 Authors Dostal A , Fehlbaum S , Chassard C , Zimmermann MB , Lacroix C , |
|
|
Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. ✅
Go to Publication ✅
FEMS microbiology ecology (FEMS Microbiol Ecol ) Vol: 83 Issue 1 Pages: 161-75 Pub: 2013 Jan Epub: 2012 Aug 28 Authors Dostal A , Fehlbaum S , Chassard C , Zimmermann MB , Lacroix C , |
|
|
Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. ✅
Go to Publication ✅
FEMS microbiology ecology (FEMS Microbiol Ecol ) Vol: 83 Issue 1 Pages: 161-75 Pub: 2013 Jan Epub: 2012 Aug 28 Authors Dostal A , Fehlbaum S , Chassard C , Zimmermann MB , Lacroix C , |
|
|
Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. ✅
Go to Publication ✅
FEMS microbiology ecology (FEMS Microbiol Ecol ) Vol: 83 Issue 1 Pages: 161-75 Pub: 2013 Jan Epub: 2012 Aug 28 Authors Dostal A , Fehlbaum S , Chassard C , Zimmermann MB , Lacroix C , |
|
|
Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. ✅
Go to Publication ✅
FEMS microbiology ecology (FEMS Microbiol Ecol ) Vol: 83 Issue 1 Pages: 161-75 Pub: 2013 Jan Epub: 2012 Aug 28 Authors Dostal A , Fehlbaum S , Chassard C , Zimmermann MB , Lacroix C , |
|
|
Microbial Metabolism Shifts Towards an Adverse Profile with Supplementary Iron in the TIM-2 In vitro Model of the Human Colon. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 6 Issue Pages: 1481 Pub: 2015 Epub: 2016 Jan 6 Authors Kortman GA , Dutilh BE , Maathuis AJ , Engelke UF , Boekhorst J , Keegan KP , Nielsen FG , Betley J , Weir JC , Kingsbury Z , Kluijtmans LA , Swinkels DW , Venema K , Tjalsma H , |
|
|
Microbial Metabolism Shifts Towards an Adverse Profile with Supplementary Iron in the TIM-2 In vitro Model of the Human Colon. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 6 Issue Pages: 1481 Pub: 2015 Epub: 2016 Jan 6 Authors Kortman GA , Dutilh BE , Maathuis AJ , Engelke UF , Boekhorst J , Keegan KP , Nielsen FG , Betley J , Weir JC , Kingsbury Z , Kluijtmans LA , Swinkels DW , Venema K , Tjalsma H , |
|
|
Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron. ✅
Go to Publication ✅
NPJ biofilms and microbiomes (NPJ Biofilms Microbiomes ) Vol: 5 Issue Pages: 26 Pub: 2019 Epub: 2019 Sep 24 Authors La Carpia F , Wojczyk BS , Annavajhala MK , Rebbaa A , Culp-Hill R , D`Alessandro A , Freedberg DE , Uhlemann AC , Hod EA , |
|
|
Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function? ✅
Nutrients (Nutrients ) Vol: 12 Issue 6 Pages: Pub: 2020 Jun 12 Epub: 2020 Jun 12 Authors Knezevic J , Starchl C , Tmava Berisha A , Amrein K , |
|
|
Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function? ✅
Nutrients (Nutrients ) Vol: 12 Issue 6 Pages: Pub: 2020 Jun 12 Epub: 2020 Jun 12 Authors Knezevic J , Starchl C , Tmava Berisha A , Amrein K , |
|
|
Effects of Iron and Zinc Biofortified Foods on Gut Microbiota In Vivo (Gallus gallus): A Systematic Review. ✅
Nutrients (Nutrients ) Vol: 13 Issue 1 Pages: Pub: 2021 Jan 9 Epub: 2021 Jan 9 Authors Juste Contin Gomes M , Stampini Duarte Martino H , Tako E , |
|
|
Dose-Responsive Effects of Iron Supplementation on the Gut Microbiota in Middle-Aged Women. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 6 Pages: Pub: 2024 Mar 10 Epub: 2024 Mar 10 Authors Shearer J , Shah S , MacInnis MJ , Shen-Tu G , Mu C , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
